["(S1 (S (S (NP (JJ Oxidative) (NN DNA) (NN damage)) (VP (VBZ correlates) (PP (IN with) (NP (NP (NN cell) (NN immortalization)) (CC and) (NP (NN mir-92) (NN expression)))) (PP (IN in) (NP (JJ hepatocellular) (NN carcinoma))))) (. .)))", "(S1 (S (NP (NP (NN BACKGROUND)) (: :) (S (S (NP (NN MicroRNAs) (NN expression)) (VP (VBZ has) (VP (VBN been) (ADVP (RB extensively)) (VP (VBN studied) (PP (IN in) (NP (JJ hepatocellular) (NN carcinoma))))))) (CC but) (S (NP (JJ little)) (VP (VBZ is) (VP (VBN known) (S (VP (VBG regarding) (NP (DT the) (NN relationship)))) (, ,) (SBAR (IN if) (FRAG (DT any))) (, ,) (PP (IN with) (NP (NP (NN inflammation)) (, ,) (NP (NP (NN production)) (PP (IN of) (NP (NP (JJ reactive) (NN oxygen) (NNS species)) (PRN (-LRB- -LRB-) (NP (NN ROS)) (-RRB- -RRB-))))) (, ,) (NP (NN host) (POS 's) (NN repair) (NNS mechanisms)) (CC and) (NP (NN cell) (NN immortalization)))))))) (. .))))", "(S1 (S (NP (DT This) (NN study)) (VP (VBD aimed) (PP (PP (IN at) (S (VP (VBG assessing) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NP (JJ oxidative) (NN DNA) (NN damage)) (PRN (-LRB- -LRB-) (NP (NN 8-hydroxydeoxyguanosine)) (: -) (NP (NN 8-OHdG)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (JJ different) (NNS phases)) (PP (IN of) (NP (DT the) (JJ carcinogenetic) (NN process)))))) (, ,) (PP (IN in) (NP (NP (NN relation)) (PP (TO to) (NP (NN DNA) (NN repair) (NN gene) (NN polymorphism))))) (, ,) (NP (JJ telomeric) (NN dysfunction))))) (CC and) (PP (TO to) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ several) (NNS microRNAs)) (, ,) (NP (NP (JJ non-coding) (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ post-transcriptional) (NN regulation)) (, ,) (NP (NN cell) (NN proliferation)) (, ,) (NP (NN differentiation)) (CC and) (NP (NN death)))))))))))) (. .)))", "(S1 (S (NP (NP (NNS METHODS)) (: :) (S (NP (NP (NN Tissue) (NNS samples)) (VP (VBN obtained) (PP (CC either) (PP (IN at) (NP (NN surgery))) (, ,) (NP (NP (NP (JJ -LSB-neoplastic)) (PRN (-LRB- -LRB-) (NP (NN HCC)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ adjacent) (JJ non-cancerous) (JJ cirrhotic) (NNS tissues)) (PRN (-LRB- -LRB-) (NP (NN NCCT)) (-RRB- -RRB-))) (-RRB- -RSB-))) (PP (IN at) (NP (NP (NN percutaneous)) (CC or) (NP (JJ laparoscopic) (NN biopsy)))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN HCV)) (CC or) (NP (JJ HBV-related) (NN hepatitis))))) (CC or) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NN cholecystectomy))))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN analysed) (PP (IN for) (NP (NP (NP (NN 8-OHdG)) (PRN (-LRB- -LRB-) (NP (JJ HPLC-ED)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN OGG1)) (PRN (-LRB- -LRB-) (NP (DT a) (NN DNA) (NN repair) (NN gene)) (-RRB- -RRB-)) (NP (NP (NN polymorphism)) (PRN (-LRB- -LRB-) (NP (NN PCR-RFLP)) (-RRB- -RRB-))) (, ,) (NP (NN telomerase) (NN activity)) (, ,) (NP (NN telomere) (NN length))) (PRN (-LRB- -LRB-) (NP (NN T/S)))) (, ,))) (PP (IN by) (NP (NP (NN RT-PCR) (-RRB- -RRB-)) (, ,) (NP (NN Taqman) (NN microRNA) (NN assay)) (CC and) (NP (NP (NN Bad/Bax) (NN mRNA)) (PRN (-LRB- -LRB-) (NP (NN RT-PCR)) (-RRB- -RRB-)))))))) (. .))))", "(S1 (S (S (NP (NP (NP (JJ Fifty-eight) (NNS samples)) (PP (IN from) (NP (CD 29) (NN HCC) (NNS patients))) (-LRB- -LRB-) (VP (VBN obtained) (PP (IN in) (NP (DT both) (JJ neoplastic) (CC and) (JJ peritumoral) (NNS tissues)))) (-RRB- -RRB-)) (, ,) (NP (NP (NP (CD 22)) (PP (IN from) (NP (JJ chronic) (NN hepatitis)))) (PRN (-LRB- -LRB-) (NP (NN CH)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 10) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN cholecystectomy) (NNS patients)) (: -) (NP (NN CON)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN examined)))) (. .)))", "(S1 (S (NP (NP (NNS RESULTS)) (: :) (S (NP (NN Eight-OHdG) (NNS levels)) (VP (VBD were) (ADVP (RB significantly)) (ADJP (ADJP (JJR higher)) (PP (IN in) (NP (NP (NN HCC)) (CC and) (NP (NN NCCT)))) (PP (IN than) (PP (IN in) (NP (NP (NN CH)) (CC and) (NP (NP (NN CON)) (PRN (-LRB- -LRB-) (NP (NN p=0.001)) (-RRB- -RRB-))))))))) (. .))))", "(S1 (S (S (NP (NN Telomerase) (NN activity)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NN HCC))) (PP (IN than) (PP (IN in) (NP (DT the) (VBG remaining) (NNS subgroups)))) (PRN (-LRB- -LRB-) (NP (NN p=0.002)) (-RRB- -RRB-))))) (: ;) (S (ADVP (RB conversely)) (NP (NN T/S)) (VP (VBD was) (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (NP (NN HCC)) (PRN (-LRB- -LRB-) (NP (NN p=0.05)) (-RRB- -RRB-)))))) (. .)))", "(S1 (S (S (NP (NP (CD MiR-199a-b)) (, ,) (NP (CD -195)) (, ,) (NP (CD -122)) (, ,) (NP (CD -92a)) (CC and) (NP (CD -145))) (VP (VBD were) (VP (VBN down-regulated) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NNS HCCs))))) (SBAR (IN while) (S (NP (NN miR-222)) (VP (VBD was) (VP (VBN up-regulated)))))))) (. .)))", "(S1 (S (S (NP (DT A) (JJ positive) (NN correlation)) (VP (VBD was) (VP (VBN observed) (PP (IN among) (NP (NP (NN 8-OHdG) (NNS levels)) (, ,) (NP (NN disease) (NN stage)) (, ,) (NP (NN telomerase) (NN activity)) (, ,) (NP (NN OGG1) (NNS polymorphisms)) (CC and) (NP (NN ALT/GGT) (NNS levels))))))) (. .)))", "(S1 (S (S (PP (IN In) (NP (NN HCC))) (, ,) (NP (NN miR-92) (NN expression)) (VP (VBD correlated) (ADVP (RB positively)) (PP (IN with) (NP (NP (NN telomerase) (NN activity)) (, ,) (NP (NN 8-OHdG) (NNS levels)) (CC and) (NP (NN Bad/Bax) (NN mRNA)))))) (. .)))", "(S1 (S (NP (NP (NNS CONCLUSIONS)) (: :) (S (NP (DT The) (JJ above) (NNS findings)) (VP (VP (VBP confirm) (NP (NP (DT the) (NN accumulation)) (, ,) (PP (IN in) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (JJ chronic) (NN liver) (NN damage))) (PP (TO to) (NP (NN HCC))))) (, ,) (PP (IN of) (NP (DT a) (JJ ROS-mediated) (JJ oxidative) (NN DNA) (NN damage))))) (, ,) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT this)) (VP (VP (VBZ correlates) (PP (IN with) (NP (NP (NN induction)) (PP (IN of) (NP (NN telomerase) (NN activity)))))) (CC and) (, ,) (PP (IN as) (NP (DT a) (JJ novel) (NN finding))) (, ,) (PP (IN with) (NP (NP (NN over-expression)) (PP (IN of) (NP (NP (NN miR-92)) (, ,) (NP (NP (DT a) (NN microRNA)) (SBAR (WHNP (WDT that)) (S (VP (VBZ plays) (NP (DT a) (NN role)) (PP (PP (IN in) (NP (PDT both) (DT the) (JJ apoptotic) (NN process))) (CC and) (PP (IN in) (NP (JJ cellular) (NN proliferation) (NNS pathways)))))))))))))))))) (. .))))"]